Ana Isabel De Lucas Olivares

USPTO Granted Patents = 6 (Patent Applications = 4)

CIPO Patents = 4 (Patent Applications = 5)

EPO Patents = 4 (Patent Applications = 8)

Average Co-Inventor Count = 4.2

ph-index = 2

Forward Citations = 10(Granted Patents)

Location History:

Toledo, ES (2007 - 2018)
Bargas, ES (2018)

Company Filing History:

3 out of 2,077

Janssen Pharmaceutica Nv

patents

3 out of 159

Janssen Pharmaceuticals, Inc.

where one patent can have more than one assignee

Years Active: 2007-2018

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10112949 - 6,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one compounds and their use as negative allosteric modulators of mGluR2 receptors (2018-10-30),

2. 10072014 - 6,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one compounds and their use as negative allosteric modulators of MGLUR2 receptors (2018-09-11),

3. 9085577 - 7-aryl-1,2,4-triazolo[4,3-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors (2015-07-21),

4. 8946205 - 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors (2015-02-03),

5. 8716480 - 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors (2014-05-06),

6. 7265103 - Substituted amino isoxazoline derivatives and their use as anti-depressants (2007-09-04),

Title: Ana Isabel De Lucas Olivares: Pioneering Innovator in Pharmacology

Introduction:

Ana Isabel De Lucas Olivares, a brilliant inventor hailing from Toledo, Spain, is making waves in the field of pharmacology with her groundbreaking patents and inventions.

Latest Patents:

Ana Isabel De Lucas Olivares holds six patents, with her latest being the innovative 6,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one compounds. These compounds act as negative allosteric modulators of the metabotropic glutamate receptor subtype 2 (mGluR2), showcasing her prowess in developing novel pharmaceutical compositions for the treatment of various disorders.

Career Highlights:

Having worked at esteemed pharmaceutical companies such as Janssen Pharmaceutica N.V. and Janssen Pharmaceuticals, Inc., Ana Isabel De Lucas Olivares has honed her skills and expertise in the field of drug development. Her contributions have been instrumental in advancing pharmacological research and treatment options for patients worldwide.

Collaborations:

Throughout her career, Ana Isabel De Lucas Olivares has collaborated with esteemed professionals in the field, including Jose Maria Cid-Nunez and Andres Avelino Trabanco-Suarez. Together, they have pushed the boundaries of pharmacology and worked towards developing cutting-edge solutions for complex medical conditions.

Conclusion:

In conclusion, Ana Isabel De Lucas Olivares stands as a trailblazing inventor and innovator in the field of pharmacology. Her dedication to scientific advancement and commitment to improving healthcare outcomes through her patented inventions are poised to leave a lasting impact on the industry.

This text is generated by artificial intelligence and may not be accurate.